Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
Neuraxpharm announces acquisition of Buccolam rights
Neuraxpharm announced an agreement to acquire the global rights to Buccolam from Takeda. The transaction was expected to close by the end of 2020, subject to customary legal and regulatory closing conditions; completion was not reported.
2019
Neuraxpharm announces acquisition of S.T.U. GmbH
Neuraxpharm announced its acquisition of S.T.U. GmbH, a Switzerland-based developer and distributor of cannabidiol consumer products. The transaction terms were not disclosed.